vaccinium myrtillus
Botanicalexperimental
Vaccinium myrtillus or European blueberry is a holarctic species of shrub with edible fruit of blue color, known by the common names bilberry, blaeberry, wimberry, and whortleberry. It is more precisely called common bilberry or blue whortleberry to distinguish it from other Vaccinium relatives. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2013 (NCT01674374)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaVaccinium myrtillus ↗
- NCATSR911H793SU ↗
Also known as
- vaccinium myrtillus
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03316612 | N/A | Nov 10, 2017 | Huazhong University of Science and Technology |
| NCT01674374 | Phase 2 | May 1, 2013 | National Cancer Institute (NCI), State University of New York, Buffalo |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 1 | 1 | 2017 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2013 |
| State University of New York, Buffalo | Academic/Hospital | 1 | 1 | 1 | 2013 |
3 organizations
Page 1 / 1